HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Atsuo Tahara Selected Research

fezolinetant

8/2021Effects of neurokinin 3 receptor antagonist fezolinetant on hot flash-like symptoms in ovariectomized rats.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Atsuo Tahara Research Topics

Disease

22Type 2 Diabetes Mellitus (MODY)
11/2021 - 07/2008
18Hyperglycemia
02/2020 - 03/2009
10Obesity
02/2020 - 03/2011
10Hypertrophy
01/2012 - 09/2002
9Glucose Intolerance
07/2018 - 12/2008
8Insulin Resistance
02/2020 - 03/2011
7Inflammation (Inflammations)
02/2020 - 09/2013
7Hyperplasia
01/2012 - 09/2002
6Fibrosis (Cirrhosis)
02/2020 - 01/2012
6Diabetic Nephropathies (Diabetic Nephropathy)
01/2020 - 11/2004
5Albuminuria
01/2020 - 11/2004
5Hypoglycemia (Reactive Hypoglycemia)
04/2012 - 05/2008
4Hyperlipidemias (Hyperlipidemia)
02/2020 - 09/2013
3Body Weight (Weight, Body)
08/2021 - 02/2009
3Heart Failure
06/2021 - 08/2002
3Hyperinsulinism (Hyperinsulinemia)
03/2018 - 09/2013
2Hyperphagia (Overeating)
08/2021 - 09/2018
2Non-alcoholic Fatty Liver Disease
06/2021 - 11/2019
2Weight Loss (Weight Reduction)
09/2018 - 03/2014
2Proteinuria
07/2018 - 01/2018
2Hypertension (High Blood Pressure)
07/2018 - 02/2003
1Weight Gain
08/2021
1Fatty Liver
08/2017
1Diabetes Complications
08/2017
1Diabetes Mellitus
01/2015
1Chronic Kidney Failure (Chronic Renal Failure)
10/2014
1Type 1 Diabetes Mellitus (Autoimmune Diabetes)
07/2014
1Metabolic Syndrome (Dysmetabolic Syndrome X)
09/2013

Drug/Important Bio-Agent (IBA)

19ipragliflozinIBA
11/2021 - 01/2012
18Glucose (Dextrose)FDA LinkGeneric
02/2020 - 12/2008
12Hypoglycemic Agents (Hypoglycemics)IBA
11/2021 - 07/2008
10Sodium-Glucose Transport ProteinsIBA
06/2021 - 01/2012
9Sodium-Glucose Transporter 2 InhibitorsIBA
06/2021 - 03/2016
9Vasopressins (Vasopressin)IBA
01/2012 - 08/2002
6Streptozocin (Streptozotocin)FDA Link
07/2014 - 12/2008
64- fluoro- 1- (((4- methyl- 1- (methylsulfonyl)piperidin- 4- yl)amino)acetyl)pyrrolidine- 2- carbonitrileIBA
11/2009 - 05/2008
5Blood Glucose (Blood Sugar)IBA
11/2021 - 02/2009
5Niacinamide (Nicotinamide)FDA LinkGeneric
09/2013 - 12/2008
4Insulin (Novolin)FDA Link
09/2013 - 12/2008
3Therapeutic UsesIBA
01/2020 - 09/2013
3Proteins (Proteins, Gene)FDA Link
10/2014 - 09/2002
3Collagen Type IV (Type IV Collagen)IBA
01/2012 - 02/2008
3Dipeptidyl-Peptidase IV InhibitorsIBA
03/2009 - 07/2008
34'- (4,4- difluoro- 5- (2- oxo- 2- (4- piperidinopiperidino)ethylidene)- 2,3,4,5- tetrahydro- 1H- 1- benzoazepine- 1- carbonyl)- 2- methyl- 3- furanilideIBA
06/2007 - 01/2006
2Pioglitazone (Actos)FDA Link
06/2021 - 11/2019
2CreatinineIBA
01/2020 - 07/2018
2AS2444697IBA
01/2020 - 10/2014
2Hormones (Hormone)IBA
09/2018 - 04/2011
2dapagliflozinIBA
08/2017 - 07/2016
2Messenger RNA (mRNA)IBA
10/2014 - 01/2012
2Fibronectins (Fibronectin)IBA
01/2012 - 05/2008
2Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA
04/2011 - 03/2011
2EnzymesIBA
05/2008 - 04/2008
2ImmunosorbentsIBA
05/2008 - 04/2008
2N- (6- methoxy- 5- (2- methoxyphenoxy)- 2- (pyrimidin- 2- yl)pyrimidin- 4- yl)- 2- phenylethenesulfonamide (YM598)IBA
06/2007 - 11/2004
2conivaptan (Vaprisol)FDA Link
11/2002 - 08/2002
24'- (4,4- difluoro- 5- (2- (4- dimethylaminopiperidino)- 2- oxoethylidene)- 2,3,4,5- tetrahydro- 1H- 1- benzoazepine- 1- carbonyl)- 2- phenylbenzanilideIBA
10/2002 - 09/2002
1Estradiol (Delestrogen)FDA LinkGeneric
08/2021
1fezolinetantIBA
08/2021
1Luteinizing Hormone (Lutropin)FDA LinkGeneric
08/2021
1Follicle Stimulating Hormone (Follitropin)FDA Link
08/2021
1ThiazolidinedionesIBA
06/2021
1Metformin (Glucophage)FDA LinkGeneric
02/2020
1Interleukin-1 Receptor-Associated KinasesIBA
01/2020
1Hexosaminidases (Hexosaminidase)IBA
01/2020
1nephrinIBA
01/2020
1GhrelinIBA
09/2018
1Neuropeptide YIBA
09/2018
1CarbohydratesIBA
03/2018
1Dietary Carbohydrates (Carbohydrate, Dietary)IBA
03/2018
16- ((4- ethylphenyl)methyl)- 3',4',5',6'- tetrahydro- 6'- (hydroxymethyl)spiro(isobenzofuran- 1(3H),2'- (2H)pyran)- 3',4',5'- triolIBA
08/2017
11,5- anhydro- 1- (5- (4- ethoxybenzyl)- 2- methoxy- 4- methylphenyl)- 1- thioglucitolIBA
08/2017
1empagliflozinIBA
08/2017
1CanagliflozinIBA
08/2017
1SodiumIBA
01/2015
1CytokinesIBA
10/2014
1C-Reactive ProteinIBA
10/2014
1Becaplermin (PDGF-BB)FDA Link
01/2012
1ThymidineIBA
01/2012
1Collagen Type I (Type I Collagen)IBA
01/2012
1Plasminogen Activator Inhibitor 1IBA
01/2012
1Connective Tissue Growth FactorIBA
01/2012
1pirfenidoneIBA
01/2012
1Plasminogen InactivatorsIBA
01/2012
1Leucine (L-Leucine)FDA Link
01/2012
1Rosiglitazone (Avandia)FDA Link
03/2011
1Sitagliptin Phosphate (Januvia)FDA Link
03/2011
1Gliclazide (Diamicron)IBA
11/2009
1Hemoglobin AIBA
02/2009
1Dipeptidyl Peptidase 4 (Dipeptidyl Peptidase IV)IBA
02/2009
1LipidsIBA
02/2009
1Triglycerides (Triacylglycerol)IBA
02/2009
1Fatty Acids (Saturated Fatty Acids)IBA
02/2009
1CholesterolIBA
02/2009
1Glucagon-Like Peptide 1 (GLP 1)IBA
01/2009
1Dipeptidyl-Peptidases and Tripeptidyl-PeptidasesIBA
01/2009

Therapy/Procedure

3Glycemic Control
03/2016 - 03/2009
2Oral Administration
08/2013 - 08/2002
1Carbohydrate-Restricted Diet (Low Carbohydrate Diet)
03/2018
1Therapeutics
03/2009